|
1
|
Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.
|
Circ Res
|
2014
|
1.93
|
|
2
|
Effect of leptin on arterial thrombosis following vascular injury in mice.
|
JAMA
|
2002
|
1.83
|
|
3
|
Murine models of vascular thrombosis (Eitzman series).
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.74
|
|
4
|
Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.
|
J Clin Invest
|
2013
|
1.64
|
|
5
|
Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice.
|
Circulation
|
2008
|
1.62
|
|
6
|
Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency.
|
Circulation
|
2005
|
1.28
|
|
7
|
Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E-deficient mice.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.22
|
|
8
|
Heparin cofactor II inhibits arterial thrombosis after endothelial injury.
|
J Clin Invest
|
2002
|
1.18
|
|
9
|
Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis.
|
Arthritis Rheum
|
2012
|
1.18
|
|
10
|
P-selectin glycoprotein ligand-1 regulates adhesive properties of the endothelium and leukocyte trafficking into adipose tissue.
|
Circ Res
|
2010
|
1.14
|
|
11
|
Ventricular tachycardia associated with transmyocardial migration of an epicardial pacing wire.
|
Ann Thorac Surg
|
2004
|
1.12
|
|
12
|
Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.08
|
|
13
|
Visceral adipose tissue and atherosclerosis.
|
Curr Vasc Pharmacol
|
2009
|
1.07
|
|
14
|
Monocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.05
|
|
15
|
Obesity-induced endothelial dysfunction is prevented by deficiency of P-selectin glycoprotein ligand-1.
|
Diabetes
|
2012
|
0.93
|
|
16
|
Acute myocardial infarction leads to acceleration of atherosclerosis.
|
Atherosclerosis
|
2013
|
0.88
|
|
17
|
Paradoxical roles of perivascular adipose tissue in atherosclerosis and hypertension.
|
Circ J
|
2012
|
0.88
|
|
18
|
P-selectin glycoprotein ligand-1 inhibition blocks increased leukocyte-endothelial interactions associated with sickle cell disease in mice.
|
Blood
|
2012
|
0.87
|
|
19
|
Atherosclerosis in mice is not affected by a reduction in tissue factor expression.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.87
|
|
20
|
Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.
|
Br J Haematol
|
2013
|
0.87
|
|
21
|
Plasminogen activator inhibitor-1 in vascular thrombosis.
|
Curr Drug Targets
|
2007
|
0.85
|
|
22
|
P-selectin glycoprotein ligand-1 deficiency leads to cytokine resistance and protection against atherosclerosis in apolipoprotein E deficient mice.
|
Atherosclerosis
|
2011
|
0.84
|
|
23
|
Atherosclerosis and leukocyte-endothelial adhesive interactions are increased following acute myocardial infarction in apolipoprotein E deficient mice.
|
Atherosclerosis
|
2010
|
0.84
|
|
24
|
Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity.
|
J Am Heart Assoc
|
2013
|
0.83
|
|
25
|
Targeting MCP-1 to reduce vascular complications of obesity.
|
Recent Pat Cardiovasc Drug Discov
|
2009
|
0.82
|
|
26
|
Blood pressure and vascular effects of leptin in humans.
|
Metab Syndr Relat Disord
|
2007
|
0.82
|
|
27
|
Alpha-galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutation.
|
Stroke
|
2006
|
0.81
|
|
28
|
Strategies to reduce vascular risk associated with obesity.
|
Curr Vasc Pharmacol
|
2007
|
0.80
|
|
29
|
Increased stroke size following MCA occlusion in a mouse model of sickle cell disease.
|
Blood
|
2014
|
0.79
|
|
30
|
Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemia.
|
Atherosclerosis
|
2010
|
0.79
|
|
31
|
Competitive bidding for interventional cardiology supplies: lessons learned during round 2.
|
Am J Manag Care
|
2002
|
0.79
|
|
32
|
Adiponectin: vascular protection from the fat?
|
Arterioscler Thromb Vasc Biol
|
2006
|
0.79
|
|
33
|
Animal models of thrombosis.
|
Curr Opin Hematol
|
2009
|
0.77
|
|
34
|
Alpha-galactosidase A in vascular disease.
|
Trends Cardiovasc Med
|
2007
|
0.77
|
|
35
|
Valsartan Improves Insulin Sensitivity without Altering Vascular Function in Healthy Overweight Adults without the Metabolic Syndrome.
|
Metab Syndr Relat Disord
|
2007
|
0.76
|
|
36
|
Haploinsufficiency of E-selectin ligand-1 is associated with reduced atherosclerotic plaque macrophage content while complete deficiency leads to early embryonic lethality in mice.
|
Atherosclerosis
|
2012
|
0.75
|
|
37
|
Recent advances in understanding endogenous fibrinolysis: implications for molecular-based treatment of vascular disorders.
|
Expert Rev Mol Med
|
2002
|
0.75
|